Articles by: Geisel Communications

Officials Wary of Zika’s Threat to NH – New Hampshire Union Leader

Read article – Cites comments by Elizabeth Talbot, associate professor of medicine, who participated in a roundtable discussion on Friday with some of the state’s top health experts to discuss the Zika virus and assess the level of risk to New Hampshire residents. Talbot traveled to West Africa in late 2014 to help protect humanitarian workers battling the Ebola epidemic, and said like Ebola, fears of the Zika virus affect the overall sense of safety even in areas where the disease is not present.

Sleep Aids Carry an Array of Risks, Including Next-Day Hangover Effects – The Boston Globe

Read article – Lisa Schwartz, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, is quoted about her work with Consumer Reports Best Buy Drugs on investigating the benefits and harms of sleeping pills. “But those benefits aren’t as great as many people assume, and the drugs have important harms,” says Schwartz.

Life Expectancy Drops For White Women, Increases For Black Men – NPR

Read article – Ellen Meara, professor of the Dartmouth Institute for Health Policy and Clinical Practice, is quoted about a report recently released by the Centers for Disease Control and Prevention’s National Center for Health Statistics, that found that white women are dying at a slightly younger age than they used to, and that the average life expectancy for non-Hispanic black men increased by about a half year. “There are people for whom life expectancy is falling—and that’s happening at a time where everywhere else and for every other group we’re seeing all these amazing gains in survival,” Meara says.

What Does ‘Breakthrough’ Mean to Docs and Consumers? It’s Not the FDA Definition – FiercePharma

Read article – Quotes Steve Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, and co-author of a recent study which found that when the FDA designates a drug as a “breakthrough” therapy, 77 percent of physicians think it means there is “high-quality evidence” that the drug is more effective than current treatments.

Mental Health Software Treats Patients as Partners in Care – Valley News

Read article – Patricia Deegan, adjunct professor of community and family medicine, recently developed the CommonGround software program that West Central, a mental health clinic in Lebanon, began using earlier this year to give a voice to patients in determining their treatment during short, routine appointments. Deegan said that she became interested in Dartmouth because of the institution’s important role in the promotion of “shared decision making” between the doctor and the patient. Deegan is working with Greg McHugo, professor of psychiatry, and others on a new study that will compare how CommonGround and another, more top-down approach affect medication visits and improve patient involvement in decision-making.